Literature DB >> 30698672

Reply to Rajasingham and Boulware.

Joseph N Jarvis1,2,3,4, Thomas S Harrison5.   

Abstract

Year:  2019        PMID: 30698672      PMCID: PMC6669295          DOI: 10.1093/cid/ciz040

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  21 in total

1.  British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011.

Authors:  Mark Nelson; David Dockrell; Simon Edwards; Brian Angus; Simon Barton; Nick Beeching; Colm Bergin; Marta Boffito; Ronan Breen; Jonathan Cartledge; Susan Clarke; Martin Fisher; Andrew Freedman; Brian Gazzard; Alison Grant; Julia Greig; Rachael Jones; Saye Khoo; Clifford Leen; Marc Lipman; Hadi Manji; Robert Miller; Suzanne Mitchell; Ed Ong; Anton Pozniak; Matthias Schmid; Marianne Shiew; Mervyn Singer; Ed Wilkins; Ian Williams; Chris Wood; Rosy Weston
Journal:  HIV Med       Date:  2011-09       Impact factor: 3.180

2.  Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis.

Authors:  Mark W Tenforde; Margaret Mokomane; Tshepo Leeme; Raju K K Patel; Nametso Lekwape; Chandapiwa Ramodimoosi; Bonno Dube; Elizabeth A Williams; Kelebeletse O Mokobela; Ephraim Tawanana; Tlhagiso Pilatwe; William J Hurt; Hannah Mitchell; Doreen L Banda; Hunter Stone; Mooketsi Molefi; Kabelo Mokgacha; Heston Phillips; Paul C Mullan; Andrew P Steenhoff; Yohana Mashalla; Madisa Mine; Joseph N Jarvis
Journal:  Clin Infect Dis       Date:  2017-09-01       Impact factor: 9.079

3.  Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial.

Authors:  Joseph N Jarvis; Tshepo B Leeme; Mooketsi Molefi; Awilly A Chofle; Gabriella Bidwell; Katlego Tsholo; Nametso Tlhako; Norah Mawoko; Raju K K Patel; Mark W Tenforde; Charles Muthoga; Gregory P Bisson; Jeremiah Kidola; John Changalucha; David Lawrence; Shabbar Jaffar; William Hope; Si le F Molloy; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2019-01-18       Impact factor: 9.079

4.  Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.

Authors:  Radha Rajasingham; Rachel M Smith; Benjamin J Park; Joseph N Jarvis; Nelesh P Govender; Tom M Chiller; David W Denning; Angela Loyse; David R Boulware
Journal:  Lancet Infect Dis       Date:  2017-05-05       Impact factor: 25.071

5.  Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis.

Authors:  Matthew Merry; David R Boulware
Journal:  Clin Infect Dis       Date:  2016-03-23       Impact factor: 9.079

6.  High Cryptococcal Antigen Titers in Blood Are Predictive of Subclinical Cryptococcal Meningitis Among Human Immunodeficiency Virus-Infected Patients.

Authors:  Rachel M Wake; Erika Britz; Charlotte Sriruttan; Ivy Rukasha; Tanvier Omar; David C Spencer; Jeremy S Nel; Sello Mashamaite; Adeboye Adelekan; Tom M Chiller; Joseph N Jarvis; Thomas S Harrison; Nelesh P Govender
Journal:  Clin Infect Dis       Date:  2018-02-10       Impact factor: 9.079

7.  Cryptococcal meningitis: A neglected NTD?

Authors:  Síle F Molloy; Tom Chiller; Gregory S Greene; Jessica Burry; Nelesh P Govender; Cecilia Kanyama; Sayoki Mfinanga; Sokoine Lesikari; Yacouba N Mapoure; Charles Kouanfack; Victor Sini; Elvis Temfack; David R Boulware; Francoise Dromer; David W Denning; Jeremy Day; Neil R H Stone; Tihana Bicanic; Joseph N Jarvis; Olivier Lortholary; Thomas S Harrison; Shabbar Jaffar; Angela Loyse
Journal:  PLoS Negl Trop Dis       Date:  2017-06-29

Review 8.  Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.

Authors:  Angela Loyse; Jessica Burry; Jennifer Cohn; Nathan Ford; Tom Chiller; Isabela Ribeiro; Sinata Koulla-Shiro; Janneth Mghamba; Angela Ramadhani; Rose Nyirenda; Sani H Aliyu; Douglas Wilson; Thuy Le; Rita Oladele; Sokoine Lesikari; Conrad Muzoora; Newton Kalata; Elvis Temfack; Yacouba Mapoure; Victor Sini; Duncan Chanda; Meshack Shimwela; Shabir Lakhi; Jonathon Ngoma; Lilian Gondwe-Chunda; Chase Perfect; Amir Shroufi; Isabelle Andrieux-Meyer; Adrienne Chan; Charlotte Schutz; Mina Hosseinipour; Charles Van der Horst; Jeffrey D Klausner; David R Boulware; Robert Heyderman; David Lalloo; Jeremy Day; Joseph N Jarvis; Marcio Rodrigues; Shabbar Jaffar; David Denning; Chantal Migone; Megan Doherty; Olivier Lortholary; Françoise Dromer; Muirgen Stack; Síle F Molloy; Tihana Bicanic; Joep van Oosterhout; Peter Mwaba; Cecilia Kanyama; Charles Kouanfack; Sayoki Mfinanga; Nelesh Govender; Thomas S Harrison
Journal:  Lancet Infect Dis       Date:  2018-10-18       Impact factor: 25.071

9.  CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.

Authors:  Nathan Ford; Zara Shubber; Joseph N Jarvis; Tom Chiller; Greg Greene; Chantal Migone; Marco Vitoria; Meg Doherty; Graeme Meintjes
Journal:  Clin Infect Dis       Date:  2018-03-04       Impact factor: 9.079

Review 10.  Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal.

Authors:  Angela Loyse; Françoise Dromer; Jeremy Day; Olivier Lortholary; Thomas S Harrison
Journal:  J Antimicrob Chemother       Date:  2013-06-20       Impact factor: 5.790

View more
  1 in total

1.  Adjunctive sertraline for asymptomatic cryptococcal antigenemia: A randomized clinical trial.

Authors:  David R Boulware; Elizabeth Nalintya; Radha Rajasingham; Paul Kirumira; Rose Naluyima; Fred Turya; Sylvia Namanda; Morris K Rutakingirwa; Caleb P Skipper; Yofesi Nikweri; Kathy Huppler Hullsiek; Ananta S Bangdiwala; David B Meya
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.